Evidence map›Paper›PMID 30318445›Full record

ArticleMolecular cell2018

Spt6 Is Required for the Fidelity of Promoter Selection.

Stephen M Doris, James Chuang, Olga Viktorovskaya, Magdalena Murawska, Dan Spatt, L Stirling Churchman, Fred Winston

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Toward structural understanding of eukaryotic transcription elongation.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Stephen M DorisDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
James ChuangDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA; Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA.
Olga ViktorovskayaDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Magdalena MurawskaDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Dan SpattDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
L Stirling ChurchmanDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Fred WinstonDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA. Electronic address: winston@genetics.med.harvard.edu.
Harvard University · USBoston University · US

Funding

Mechanisms of Transcriptional Control Revealed by Nascent Transcript SequencingR01HG007173 · NHGRI · HARVARD MEDICAL SCHOOL · PI Lee Stirling Churchman · 2013 to 2026
$6.7M
INSERTION MUTATION SUPPRESSORS IN YEASTR01GM032967 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WINSTON, FRED M. · 1985 to 2017
$3.6M
Defining the cellular functions of the conserved transcription complex Spt6/Iws1 in the control of gene expressionF32GM119291 · NIGMS · HARVARD MEDICAL SCHOOL · PI VIKTOROVSKAYA, OLGA V. · 2016 to 2018
$178k
NHGRI NIH HHS R01 HG007173NIGMS NIH HHS F32 GM119291NIGMS NIH HHS R01 GM032967
6 · The paper itself

Abstract

Spt6 is a conserved factor that controls transcription and chromatin structure across the genome. Although Spt6 is viewed as an elongation factor, spt6 mutations in Saccharomyces cerevisiae allow elevated levels of transcripts from within coding regions, suggesting that Spt6 also controls initiation. To address the requirements for Spt6 in transcription and chromatin structure, we have combined four genome-wide approaches. Our results demonstrate that Spt6 represses transcription initiation at thousands of intragenic promoters. We characterize these intragenic promoters and find sequence features conserved with genic promoters. Finally, we show that Spt6 also regulates transcription initiation at most genic promoters and propose a model of initiation site competition to account for this. Together, our results demonstrate that Spt6 controls the fidelity of transcription initiation throughout the genome.

Indexed as

ChromatinGene Expression Regulation, FungalHistone ChaperonesHistonesNuclear ProteinsNucleosomesPeptide Elongation FactorsPromoter Regions, GeneticRNA Polymerase IISaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSchizosaccharomyces pombe ProteinsTranscriptional Elongation FactorsTranscription FactorsTranscription, GeneticTranscription Initiation, GeneticChromatinHistone ChaperonesHistonesNuclear ProteinsNucleosomesPeptide Elongation FactorsRNA Polymerase IISaccharomyces cerevisiae ProteinsSchizosaccharomyces pombe ProteinsSPT6 protein, S cerevisiaeSpt6 protein, S pombeTranscriptional Elongation FactorsTranscription Factorschromatin structureintragenic promotersSpt6transcription start sites

Identifiers

PMID30318445
PMCPMC6239972
OpenAlexW2807764897

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.